The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer

Title
The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer
Authors
Keywords
Journal
Oncotarget
Volume 7, Issue 27, Pages -
Publisher
Impact Journals, LLC
Online
2016-05-22
DOI
10.18632/oncotarget.9392

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation